Dissociation between metabolic and efficiency effects of perhexiline in normoxic rat myocardium

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 6, 2005, Pages 849-855

  Unger, Steven A ^a   Kennedy, Jennifer A ^a,b   McFadden Lewis, Kate ^a   Minerds, Kirsty ^a   Murphy, Geraldine A ^a   Horowitz, John D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Cardiac efficiency; Cardiomyocytes; Carnitine palmitoyltransferase; Glucose; Oxfenicine; Palmitate; Perhexiline

Indexed keywords

ANTIANGINA PECTORIS AGENT; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRASNFERASE 2; GLUCOSE; INSULIN; LONG CHAIN FATTY ACID; OXFENICINE; OXYGEN; PALMITIC ACID; PERHEXILINE MALEATE; UNCLASSIFIED DRUG; 4-HYDROXYPHENYLGLYCINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GLYCINE; PERHEXILINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE OXIDATION; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART WORK; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; HEART RATE; METABOLISM; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CELLS, CULTURED; ENZYME INHIBITORS; GLUCOSE; GLYCINE; HEART RATE; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PALMITIC ACID; PERHEXILINE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 33644699985     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000190488.77434.f1     Document Type: Article

References (28)

1. Higgins AJ, Morville M, Burges RA, et al. Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart. Life Sci. 1980;27:963-970.
2. Lopaschuk GD, Spafford M. Response of isolated working rat hearts to fatty acids and carnitine palmitoytransferase 1 inhibition during reduction in coronary flow in acutely and chronically diabetic rats. Circ Res. 1989;65:378-387.
3. Vaughan-Williams EM. Anti-Arrhythmic Action and the Puzzle of Perhexiline. London: Academic Press; 1980.
4. Kennedy JA, Unger SA, Horowitz JD. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem Pharmacol. 1996;52:273-280.
5. Kennedy JA, Kiosoglous AJ, Murphy GA, et al. Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. J Cardiovasc Pharmacol. 2000;36:794-801.
6. Jeffrey FMH, Alvarez L, Diczku V, et al. Direct evidence that perhexiline modifies myocardial substrate utilization from fatty acid to glycolytic sources. J Cardiovasc Pharmacol. 1995;25:469-472.
7. Willoughby SR, Stewart S, Chirkov YY, et al. Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide. Eur Heart J. 2002;23:1946-1954.
8. Deschamps D, DeBeco V, Fisch C, et al. Inhibition by perhexiline of oxidative phosphorylation and the b-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology. 1994;19:948-961.
9. Lopaschuk GD, Barr RL. Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart. Mol Cell Biochem. 1997;172:137-147.
10. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980;102:344-352.
11. Grossman W (ed). Cardiac Catheterization and Angiography. 3rd ed. Lea and Febiger; 1986:546.
12. Bergmeyer HU. Methods in Enzymatic Analysis: Nucleotides, Coenzymes and Related Compounds. 3rd ed. 1983:340.
13. Buttery JE, Chamberlain BR, Milner CR. Colorimetric measurement of plasma lactate. Am J Clin Pathol. 1985;84:363-365.
14. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
15. MacInnes A, Fairman DA, Binding P, et al. The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2003;93:e26-e32.
16. Lopaschuk GD, Barr R, Thomas PD, et al. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2003;93:e33-e37.
17. Unger SA, Robinson MA, Horowitz JD. Perhexiline improves symptomatic status in elderly patients with severe aortic stenosis. Aust N Z J Med. 1997;27:24-28.
18. Lee L, Campbell R, Scheuermann-Freestone M, et al. Metabolic modulation with perhexiline in chronic heart failure: a randomized controlled trial on short term use of a novel treatment. Circulation. 2005. (in press).
19. Chavez PN, Stanley WC, McElfresh TA, et al. Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia. Am J Physiol Heart Circ Physiol. 2003;284:H1521-H1527.
20. Chandler MP, Chavez PN, McElfresh TA, et al. Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia. Cardiovasc Res. 2003;59:143-151.
21. McCormack JG, Barr RL, Wolff AA, et al. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation. 1996;93:135-142.
22. Boehm EA, Jones BE, Radda GK, et al. Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart Circ Physiol. 2001;280:H977-H983.
23. Ferdinandy P, Panas D, Schulz R. Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am J Physiol. 1999;276:H1861-H1867.
24. Lee JA, Allen DG. Calcium sensitisers: mechanisms of action and potential usefulness as inotropes. Cardiovasc Res. 1997;36:10-20.
25. Silver PJ, Dachiw J, Ambrose JM, et al. Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function. J Pharmacol Exp Ther. 1985;234:629-635.
26. Morano I, Isac M, Bletz C, et al. Perhexiline increases calcium-activated force in skinned psoas fibres by raising calcium affinity for troponin-C. Biomed Biochim Acta. 1989;48:S329-S334.
27. Xia Y, Buja LM, McMillin JB. Change in expression of heart carnitine palmitoyltransferase isoforms with electrical stimulation of cultured rat neonatal cardiac myocytes. J Biol Chem. 1996;271:12082-12087.
28. Barry WH, Horowitz JD, Smith TW. Comparison of negative inotropic potency, reversibility, and effects of calcium influx of six calcium channel antagonists in cultured myocardial cells. Br J Pharmacol. 1985;85:51-59.